233 related articles for article (PubMed ID: 26476418)
1. Extent of lymph node dissection and overall survival in patients with uterine carcinosarcoma, papillary serous and endometrioid adenocarcinoma: A retrospective cohort study.
Alagkiozidis I; Weedon J; Grossman A; Wang P; Mize B; Wilson K; Shah T; Economos K; Salame G; Abulafia O; Lee YC
Int J Surg; 2015 Dec; 24(Pt A):9-13. PubMed ID: 26476418
[TBL] [Abstract][Full Text] [Related]
2. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
Prueksaritanond N; Chantape W
J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
[TBL] [Abstract][Full Text] [Related]
3. Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study.
Alagkiozidis I; Grossman A; Tang NZ; Weedon J; Mize B; Salame G; Lee YC; Abulafia O
Int J Surg; 2015 Feb; 14():61-6. PubMed ID: 25576762
[TBL] [Abstract][Full Text] [Related]
4. Survival after pelvic exenteration for uterine malignancy: A National Cancer Data Base study.
Seagle BL; Dayno M; Strohl AE; Graves S; Nieves-Neira W; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):472-478. PubMed ID: 27760707
[TBL] [Abstract][Full Text] [Related]
5. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis.
Nemani D; Mitra N; Guo M; Lin L
Gynecol Oncol; 2008 Oct; 111(1):82-8. PubMed ID: 18674808
[TBL] [Abstract][Full Text] [Related]
6. Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.
Fader AN; Java J; Tenney M; Ricci S; Gunderson CC; Temkin SM; Spirtos N; Kushnir CL; Pearl ML; Zivanovic O; Tewari KS; O'Malley D; Hartenbach EM; Hamilton CA; Gould NS; Mannel RS; Rodgers W; Walker JL
Gynecol Oncol; 2016 Dec; 143(3):460-465. PubMed ID: 27743738
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of aortic lymph node metastasis in endometrial cancer: Potential implications for selective aortic lymph node assessment.
Cosgrove CM; Cohn DE; Rhoades J; Felix AS
Gynecol Oncol; 2019 Jun; 153(3):505-510. PubMed ID: 30935714
[TBL] [Abstract][Full Text] [Related]
8. Lymphadenectomy in Early-Stage Intermediate-/High-Risk Endometrioid Endometrial Cancer: Clinical Characteristics and Outcomes in an Australian Cohort.
Farrell R; Dixon SC; Carter J; Webb PM
Int J Gynecol Cancer; 2017 Sep; 27(7):1379-1386. PubMed ID: 30814240
[TBL] [Abstract][Full Text] [Related]
9. Impact of Chemotherapy and Radiotherapy on Management of Early Stage Clear Cell and Papillary Serous Carcinoma of the Uterus.
Hong JC; Foote J; Broadwater G; Gaillard S; Havrilesky LJ; Chino JP
Int J Gynecol Cancer; 2017 May; 27(4):720-729. PubMed ID: 28375927
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma.
Şükür YE; Taşkın S; Varlı B; Ateş C; Güngör M; Ortaç F
Int J Clin Oncol; 2018 Feb; 23(1):114-120. PubMed ID: 28836024
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological characteristics, treatment and outcomes in uterine carcinosarcoma and grade 3 endometrial cancer patients: a comparative study.
Zhu J; Wen H; Bi R; Wu X
J Gynecol Oncol; 2016 Mar; 27(2):e18. PubMed ID: 26463439
[TBL] [Abstract][Full Text] [Related]
12. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
[TBL] [Abstract][Full Text] [Related]
13. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers.
Vogel TJ; Knickerbocker A; Shah CA; Schiff MA; Isacson C; Garcia RL; Goff BA
J Gynecol Oncol; 2015 Jan; 26(1):25-31. PubMed ID: 25376917
[TBL] [Abstract][Full Text] [Related]
14. Survival advantage associated with multimodal therapy in women with node-positive (stage-IIIC) uterine papillary serous carcinoma: a National Cancer Database study.
Lin JF; Muñiz K; Sukumvanich P; Gehrig P; Beriwal S; Kelley JL; Edwards RP; Olawaiye AB
BJOG; 2016 Oct; 123(11):1846-52. PubMed ID: 26537059
[TBL] [Abstract][Full Text] [Related]
15. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
[TBL] [Abstract][Full Text] [Related]
16. Lymphadenectomy and Adjuvant Therapy Improve Survival with Uterine Carcinosarcoma: A Large Retrospective Cohort Study.
Versluis MAC; Pielsticker C; van der Aa MA; de Bruyn M; Hollema H; Nijman HW
Oncology; 2018; 95(2):100-108. PubMed ID: 29791913
[TBL] [Abstract][Full Text] [Related]
17. Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer.
Amit M; Tam S; Boonsripitayanon M; Cabanillas ME; Busaidy NL; Grubbs EG; Lai SY; Gross ND; Sturgis EM; Zafereo ME
JAMA Otolaryngol Head Neck Surg; 2018 Feb; 144(2):108-114. PubMed ID: 29192312
[TBL] [Abstract][Full Text] [Related]
18. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
[TBL] [Abstract][Full Text] [Related]
19. Survival implications of staging lymphadenectomy for non-endometrioid endometrial cancers.
Venigalla S; Chowdhry AK; Shalowitz DI
Gynecol Oncol; 2018 Jun; 149(3):531-538. PubMed ID: 29559170
[TBL] [Abstract][Full Text] [Related]
20. Uterine papillary serous carcinoma (UPSC): a single institution review of 129 cases.
Slomovitz BM; Burke TW; Eifel PJ; Ramondetta LM; Silva EG; Jhingran A; Oh JC; Atkinson EN; Broaddus RR; Gershenson DM; Lu KH
Gynecol Oncol; 2003 Dec; 91(3):463-9. PubMed ID: 14675663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
